Atyr Pharma Inc ATYR

$6.12 +1.18 (23.89%)

Valuation

Market cap
12,114,000
Revenue TTM
$190,000
Net income TTM
$-74,120,000
P/E (trailing)
0.00
P/E (forward)
—
Profit margin
-39,010.53%
Debt to equity
0.00

Trading

Volume
304,155
Avg volume
113,647
Day's range
$5.03 – $6.42
Shares out
2,452,000
Stochastic %K
28%
Beta
0.91
Analysts
Moderate Buy
Price target
$110.00

Price

Company profile

aTyr Pharma, Inc., a clinical stage biotechnology company, engages in the discovery and development of product candidates that translate tRNA synthetase biology into new therapies for fibrosis and inflammation in the United States. Its lead therapeutic candidate efzofitimod, a selective modulator of NRP2 that is in Phase 3 clinical trial for the treatment of pulmonary sarcoidosis; Phase 2 clinical trial to treat Sarc...

Show more

aTyr Pharma, Inc., a clinical stage biotechnology company, engages in the discovery and development of product candidates that translate tRNA synthetase biology into new therapies for fibrosis and inflammation in the United States. Its lead therapeutic candidate efzofitimod, a selective modulator of NRP2 that is in Phase 3 clinical trial for the treatment of pulmonary sarcoidosis; Phase 2 clinical trial to treat Sarcoidosis and systemic sclerosis- interstitial lung disease (ILDs); and treatment of other ILDs, such as chronic hypersensitivity pneumonitis (CHP) and connective tissue disease related ILD. The company is developing ATYR0101, a fusion protein derived from a domain of aspartyl-tRNA synthetase, which is in preclinical development for the treatment of fibrosis; and ATYR0750, a domain of alanyl-tRNA synthetase for the treatment of liver disorders. It has collaboration and license agreement with Kyorin Pharmaceutical Co., Ltd. for the development and commercialization of efzofitimod for ILDs in Japan. aTyr Pharma, Inc. was incorporated in 2005 and is headquartered in San Diego, California.

Industry
Biotechnology
Sector
Healthcare
Phone
858 731 8389
Website
https://atyrpharma.com
Address
10240 Sorrento Valley Road, Suite 300, San Diego, United States

Latest news

Stocktwits

Benny_Cellura Nov 2, 7:00 PM
$ATYR $SCAG $PARA.X $NUWE $ENLV cc
0 replies
topstockalerts Nov 2, 6:49 PM
Top Gainers PT2 $WETO $ATYR $LITB $MSC $CVKD
0 replies
Benny_Cellura Nov 2, 6:34 PM
$XCH.X $BYSI $ATYR $NMRA .
0 replies
Houzehero Nov 2, 6:25 PM
$ATYR Today makes your point irrelevant little ducky 🐥
1 replies
topstockalerts Nov 2, 5:30 PM
Midday Top Gainers PT2 $WETO $ATYR $LITB $MSC $CVKD
0 replies
NNTrader Nov 2, 5:14 PM
$ATYR
0 replies
hafstein Nov 2, 4:29 PM
$ATYR I used to waych this stock a year ago and it’s disappointing to see it went this low. Is it still a buy? any hope here? still deciding!!
1 replies
SmartMoneyTradez Nov 2, 3:58 PM
$INLF Struggling to breakout but $ATYR did breakout above yesterdays high. Waiting for breakout restest hold for entry
0 replies